AAPGV Ascentage Pharma Group Net Sales Margin

Public company logo of Ascentage Pharma (AAPGV)

Ascentage Pharma Group (AAPGV) is scaling its oncology portfolio through global partnerships to achieve profitability. Its developments are based on the creation of small molecules against tumors, with success relying on international patent protection and clinical trials. Tracking the aggregate net profit margin on GURU.Markets, we note that the current value is -229.30, which reflects the current efficiency of the business's operating expenses.

ascentage.com (AAPGV) Net Return on Sales: for the period 01/25/2025 - 11/19/2026

AAPGV (Ascentage Pharma Group Ltd): analytical breakdowns and indicator data

Fundamental company analysis:Ascentage - AAPGV
Flagship merchandise of Ascentage Pharma Group International

Evaluating the margin of safety for Ascentage Pharma Group (AAPGV), I focus on the efficiency of converting revenue into net income. This metric measures the share of residual income after deducting all operating and tax expenses. Analyzing the net margin allows for the separation of market noise from actual expense management discipline. The stability of this chart is supported by cost optimization through deep outsourcing of research and production. Seamless interaction with vendors minimizes production risks, maintaining margin sustainability.

Analysis of competing companies

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Xenetic Bio (XBIO)|Net Margin SLRX (Salarius Pharma)|Kitov Pharma - Return on Sales by Net Profit|American Oncology Network (AONC) - Net Margin|BeiGene - Net Sales Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Sales by Net Profit|ELEV (Elevation Oncology, Inc.) - Return on Sales by Net Profit|iCAD Inc. - Net Profit Rate|Return on Sales by Net Profit IKNA|Net Sales Margin notablelabs.com|Return on Sales by Net Profit VIRX (Viracta Therapeutics Inc.)|MOR - Net Margin|Net Margin NAYA Biosciences NAYA